N-methyl-D-aspartate antagonists, schizophrenia, and neuroleptic malignant syndrome

Arch Neurol. 1992 Sep;49(9):900-1. doi: 10.1001/archneur.1992.00530330018007.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Dopamine / metabolism
  • Humans
  • N-Methylaspartate / antagonists & inhibitors*
  • Neuroleptic Malignant Syndrome / drug therapy*
  • Parkinson Disease / drug therapy
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Schizophrenia / drug therapy*

Substances

  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • Dopamine